Literature DB >> 25149112

HCV cirrhosis at the edge of decompensation: will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?

Tarik Asselah1, Savino Bruno2, Antonio Craxi3.   

Abstract

Entities:  

Keywords:  Advanced liver disease; Direct-acting antivirals; Liver function; Portal hypertension

Mesh：

Substances：

Year:  2014        PMID： 25149112     DOI： 10.1016/j.jhep.2014.08.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

Review 1.  Chronic hepatitis C: This and the new era of treatment.

Authors:  Gaetano Bertino; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Shirin Demma; Maria Irene Ruggeri; Laura Scuderi; Giulia Malaguarnera; Nicoletta Bertino; Venerando Rapisarda; Isidoro Di Carlo; Adriana Toro; Federico Salomone; Mariano Malaguarnera; Emanuele Bertino; Michele Malaguarnera
Journal:  World J Hepatol       Date:  2016-01-18

2.  The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay.

Authors:  Toshiki Kan; Senju Hashimoto; Naoto Kawabe; Michihito Murao; Takuji Nakano; Hiroaki Shimazaki; Kazunori Nakaoka; Masashi Ohki; Yuka Takagawa; Takamitsu Kurashita; Tomoki Takamura; Kentaro Yoshioka
Journal:  J Gastroenterol       Date:  2015-04-24       Impact factor: 7.527
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.